Clozapine for Patients With Intellectual Disabilities: A Case Series Illustrating the Clinical Potentials
We suggest that clozapine should be considered in patients with ID regardless of a primary psychiatric disorder when CB does not respond to non-pharmacological and first line pharmacological treatment. It is possible to monitor and manage side-effects with a systematic approach including the use of POC testing.
Authors
- Jimmi Nielsen (ORCID: https://orcid.org/0000-0002-9868-7028)
- Magnus Roland Balleby (ORCID: https://orcid.org/0009-0000-1031-9494)
- Jacob Bentsen (ORCID: https://orcid.org/0009-0005-4647-2534)
Institutions
- Glostrup Hospital (DK)
- Copenhagen University Hospital (DK)
Publication Details
- Journal
- Case Reports in Psychiatry
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1155/crps/9592396
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00